Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria

Published:2017-12 Issue:12 Volume:70 Page:1143-1144
ISSN:1885-5857
Container-title:Revista Española de Cardiología (English Edition)
language:en
Short-container-title:Revista Española de Cardiología (English Edition)

Author:

Cebrián Cuenca Ana M.,Orozco Beltrán Domingo,Navarro Pérez Jorge,Álvarez-Guisasola Fernando,Núñez Villota Julio,Consuegra-Sánchez Luciano

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial;Scirica;Circulation.,2015

2. Update in cardiology: vascular risk and cardiac rehabilitation;Galve;Rev Esp Cardiol.,2015

3. Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?;Cebrián-Cuenca;Int J Cardiol.,2016

4. Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study;Fu;Diabetes Care.,2016

5. Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System;Raschi;Nutr Metab Cardiovasc Dis.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP